EARS - Auris Medical Holding Ltd.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 56.03M
Enterprise Value 35.06M
Trailing P/E N/A
Forward P/E 1-0.62
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) -0.22
52-Week Change 3922.73%
S&P500 52-Week Change 34.88%
52 Week High 339.4000
52 Week Low 30.2500
50-Day Moving Average 32.7479
200-Day Moving Average 35.6799

Share Statistics

Avg Vol (3 month) 3283.33k
Avg Vol (10 day) 351.88k
Shares Outstanding 5N/A
Float 1.55M
% Held by Insiders 116.57%
% Held by Institutions 14.68%
Shares Short (Jun 28, 2019) 4205.83k
Short Ratio (Jun 28, 2019) 40.56
Short % of Float (Jun 28, 2019) 413.16%
Short % of Shares Outstanding (Jun 28, 2019) 49.21%
Shares Short (prior month May 31, 2019) 4127.78k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 220/1
Last Split Date 3May 1, 2019

Financial Highlights

Currency in CHF.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-49.43%
Return on Equity (ttm)-1,545.80%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-1.3270
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)39.33
Current Ratio (mrq)1.33
Book Value Per Share (mrq)-0.03

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A